Movement Alert｜Boston Scientific Pre-Market Rise 3.47%, Blackstone collaboration backs VITALYST heart pump development

Market Focus11-04 20:21

On November 4, Boston Scientific rose 3.47% in Pre-Market Trading, trading at $45.2 per share, with turnover of $510,900.

The move followed news that Blackstone Life Sciences and Boston Scientific agreed to a $455 million collaboration to co-fund development of the VITALYST heart pump for patients with cardiogenic shock.

Under the agreement, the partners will jointly support development of a temporary percutaneous transvalvular circulatory support system designed to increase cardiac output and improve blood flow to the brain and other vital organs. The project also marks the first time Blackstone Life Sciences and Boston Scientific have co-funded development of a Boston Scientific product, reinforcing investor focus on the company’s cardiovascular pipeline after recent pressure from lower guidance and disruption tied to a cybersecurity incident.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment